BioInvent signs Licensing Agreement with Mitsubishi Tanabe Pharma for the Discovery and Development of Therapeutic Antibodies
04-Aug-2009 -
BioInvent International AB announces that it has signed a license agreement with Mitsubishi Tanabe Pharma Corporation for the development of antibodies, up to five therapeutic targets, from BioInvent’s n-CoDeR® library. Under the terms of the agreement, Mitsubishi Tanabe will be granted access ...
antibodies
antibody fragments
license agreements
+3